Loading...
| A04687 | Pages: 343 | Apr 2021 | 7654 Views | | |
| Author(s) : Sushant Terdale, Stephy Varghese , Onkar Sumant | Tables: 256 | Charts: 56 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Enteral Nutrition Market
Request Now !The global enteral nutrition market was valued at $6,762 million in 2018 and is projected to reach $12,294 million by 2027, registering a CAGR of 7.1% from 2020 to 2027.
Enteral nutrition market is expected witness modest growth during this pandemic period owing to the usage of enteral nutrition during COVID treatment.
Enteral nutrition refers to any method of feeding that involves the intake of food through gastrointestinal tract to fulfill an individual’s caloric requirements. Further, it can also include a normal diet, use of liquid or powdered supplements, and tube feeding. There are various equipment and instruments available for the patient to take enteral nutrition. These include tubes, pumps, and other pipes, which help in easy flow of fluid directly to the gastrointestinal tract. The enteral nutrition is required for the individuals suffering from diabetes, malnutrition, cancer, gastrointestinal disorders, and other complications. In addition, enteral nutrition can be provided for the patients with nutritional deficits.
Get more information on this report : Request Sample Pages
The increase in prevalence of chronic disorders such as cancer and neurological disorders is the major factor that contributes toward the growth of the enteral nutrition market. Other factors that fuel the market growth include surge in geriatric population and rise in malnutrition cases. In addition, enteral nutrition is gaining high acceptance rate, owing to enhancement in techniques, and inclusion of proper ingredients into the composition of the products. However, decreased demand from the underdeveloped countries is anticipated to hamper the market growth. Conversely, high market potential in untapped emerging economies is expected to provide lucrative opportunities for the growth of the market.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The demand for enteral nutrition increased, with the advent of COVID-19, owing to the high nutritional risks of the COVID-19 patients. The patients suffering from COVID-19 require intensive care management. In addition, nutritional deficits caused during the condition offered growth opportunities for the enteral nutrition market. Furthermore, appropriate nutrition is required when the patient is suffering from COVID-19, owing to the alterations in metabolism pattern and gastrointestinal function. Hence, optimal nutrition therapy helps the patients manage the nutritional deficits and manage further complications such as poor glycemic control, and delay in gastric emptying. Enteral nutrition helps in faster absorption to the gastric walls, owing to the forms in which it is available such as powdered and liquid form.
The enteral nutrition market is segmented into protein composition, form, age group, distribution channel, and region. By protein composition, the market is divided into standard protein diet, high protein supplement, protein for diabetes care patient, and others. By form, the market is categorized into powder and liquid. By age group, the market is bifurcated into adults (above 18) and pediatric (below 18). By distribution channel, the market is segmented into hospital sales, retail, and online. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Get more information on this report : Request Sample Pages
Presently, on the basis of protein composition, the standard protein diet dominated the global enteral nutrition market in 2018, and is anticipated to continue this trend during the forecast period. Key factors such as high adoption of standard protein diet, owing to the fact that it is one of the most preferable composition prescribed for patients suffering from diabetes, cancer, and other conditions where they have difficulty in ingesting solid food. Different product launches of the standard protein rich products, are fulfilling the market demand. Furthermore, there has been a steep increase in products, which are originated from the organic products, and hence there has been a growth in demand for standard protein diet.
In addition, the enteral nutrition market on the basis of distribution channel is segmented into hospital sales, retail, and online. The hospital sales segment accounted for maximum market revenue in 2018, and is anticipated to gain dominance in the coming years. This attributes to the greater number of inpatients and outpatients in the hospital. Furthermore, the hospital sales segment is anticipated to grow owing to higher preference of the patients for hospitals.
Get more information on this report : Request Sample Pages
Asia-Pacific presents lucrative opportunities for key players operating in the enteral nutrition market, owing to increase in patient population suffering from diseases such as cancer, neurological disorders, gastrointestinal disorders, diabetes, and other chronic conditions, increase in geriatric population in emerging economies, development of the R&D sector, rise in healthcare reforms, and technological advancements in enteral nutrition products. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the enteral nutrition market in the region.
The key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, Danone S.A., Fresenius Kabi AG, Global Health Products, Inc., Hormel Foods Corporation, Meiji Holdings Co., Ltd., Nestlé S.A., Reckitt Benckinser Group PLC, and Victus, Inc.
Get more information on this report : Request Sample Pages
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2018
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Growth in incidence of chronic diseases
3.5.1.2.Rapid growth in geriatric population
3.5.1.3.Rise in number of malnutrition cases
3.5.1.4.High adoption of enteral nutrition over parenteral nutrition
3.5.2.Restraint
3.5.2.1.Poor demand in underdeveloped countries
3.5.3.Opportunities
3.5.3.1.Growth opportunities in emerging markets
3.5.4.Impact analysis
3.6.List of key brands (up to 5)
3.6.1.Adult oral (sip feed) enteral nutrition
3.6.2.Adult tube feeding enteral nutrition
3.6.3.Pediatric oral (sip feed) enteral nutrition
3.6.4.Pediatric tube feeding enteral nutrition
3.6.5.Pediatric tolerance infant formula
3.6.6.Pediatric extensively hydrolyzed and amino acid infant formula
3.7.Sales data for key brands
3.8.Covid-19 Impact analysis on enteral nutrition market
CHAPTER 4:ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITIONS
4.1.Overview
4.1.1.Market size and forecast
4.2.Standard protein diet
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.List on key brands (up to 10)
4.3.High protein supplement
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.4.List on key brands (up to 10)
4.4.Protein for diabetes care patient
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.4.4.List on key brands (up to 10)
4.5.Others
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.5.4.List on key brands (up to 10)
CHAPTER 5:ENTERAL NUTRITION MARKET, BY FORM
5.1.Overview
5.1.1.Market size and forecast
5.2.Powder
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Liquid
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:ENTERAL NUTRITION MARKET, BY AGE GROUP
6.1.Overview
6.1.1.Market size and forecast by age group
6.2.Adults (above 18)
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.List on key brands (up to 10)
6.3.Pediatric (below 18)
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.3.3.List on key brands (up to 10)
CHAPTER 7:ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospital sales
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Retail
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
7.4.Online
7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country
CHAPTER 8:ENTERAL NUTRITION MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S.
8.2.2.1.1.Market size and forecast, by protein composition
8.2.2.1.2.Market size and forecast, by form
8.2.2.1.3.Market size and forecast, by age group
8.2.2.1.4.Market size and forecast, by distribution channel
8.2.2.2.Canada
8.2.2.2.1.Market size and forecast, by protein composition
8.2.2.2.2.Market size and forecast, by form
8.2.2.2.3.Market size and forecast, by age group
8.2.2.2.4.Market size and forecast, by distribution channel
8.2.2.3.Mexico
8.2.2.3.1.Market size and forecast, by protein composition
8.2.2.3.2.Market size and forecast, by form
8.2.2.3.3.Market size and forecast, by age group
8.2.2.3.4.Market size and forecast, by distribution channel
8.2.3.North America market size and forecast, by protein composition
8.2.4.North America market size and forecast, by form
8.2.5.North America market size and forecast, by age group
8.2.6.North America market size and forecast, by distribution channel
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany
8.3.2.1.1.Market size and forecast, by protein composition
8.3.2.1.2.Market size and forecast, by form
8.3.2.1.3.Market size and forecast, by age group
8.3.2.1.4.Market size and forecast, by distribution channel
8.3.2.2.France
8.3.2.2.1.Market size and forecast, by protein composition
8.3.2.2.2.Market size and forecast, by form
8.3.2.2.3.Market size and forecast, by age group
8.3.2.2.4.Market size and forecast, by distribution channel
8.3.2.3.UK
8.3.2.3.1.Market size and forecast, by protein composition
8.3.2.3.2.Market size and forecast, by form
8.3.2.3.3.Market size and forecast, by age group
8.3.2.3.4.Market size and forecast, by distribution channel
8.3.2.4.Italy
8.3.2.4.1.Market size and forecast, by protein composition
8.3.2.4.2.Market size and forecast, by form
8.3.2.4.3.Market size and forecast, by age group
8.3.2.4.4.Market size and forecast, by distribution channel
8.3.2.5.Spain
8.3.2.5.1.Market size and forecast, by protein composition
8.3.2.5.2.Market size and forecast, by form
8.3.2.5.3.Market size and forecast, by age group
8.3.2.5.4.Market size and forecast, by distribution channel
8.3.2.6.Rest of Europe
8.3.2.6.1.Market size and forecast, by protein composition
8.3.2.6.2.Market size and forecast, by form
8.3.2.6.3.Market size and forecast, by age group
8.3.2.6.4.Market size and forecast, by distribution channel
8.3.3.Europe market size and forecast, by protein composition
8.3.4.Europe market size and forecast, by form
8.3.5.Europe market size and forecast, by age group
8.3.6.Europe market size and forecast, by distribution channel
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan
8.4.2.1.1.Market size and forecast, by protein composition
8.4.2.1.2.Market size and forecast, by form
8.4.2.1.3.Market size and forecast, by age group
8.4.2.1.4.Market size and forecast, by distribution channel
8.4.2.2.China
8.4.2.2.1.Market size and forecast, by protein composition
8.4.2.2.2.Market size and forecast, by form
8.4.2.2.3.Market size and forecast, by age group
8.4.2.2.4.Market size and forecast, by distribution channel
8.4.2.3.Australia
8.4.2.3.1.Market size and forecast, by protein composition
8.4.2.3.2.Market size and forecast, by form
8.4.2.3.3.Market size and forecast, by age group
8.4.2.3.4.Market size and forecast, by distribution channel
8.4.2.4.India
8.4.2.4.1.Market size and forecast, by protein composition
8.4.2.4.2.Market size and forecast, by form
8.4.2.4.3.Market size and forecast, by age group
8.4.2.4.4.Market size and forecast, by distribution channel
8.4.2.5.South Korea
8.4.2.5.1.Market size and forecast, by protein composition
8.4.2.5.2.Market size and forecast, by form
8.4.2.5.3.Market size and forecast, by age group
8.4.2.5.4.Market size and forecast, by distribution channel
8.4.2.6.Rest of Asia-Pacific
8.4.2.6.1.Market size and forecast, by protein composition
8.4.2.6.2.Market size and forecast, by form
8.4.2.6.3.Market size and forecast, by age group
8.4.2.6.4.Market size and forecast, by distribution channel
8.4.3.Asia-Pacific market size and forecast, by protein composition
8.4.4.Asia-Pacific market size and forecast, by form
8.4.5.Asia-Pacific market size and forecast, by age group
8.4.6.Asia-Pacific market size and forecast, by distribution channel
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil
8.5.2.1.1.Market size and forecast, by protein composition
8.5.2.1.2.Market size and forecast, by form
8.5.2.1.3.Market size and forecast, by age group
8.5.2.1.4.Market size and forecast, by distribution channel
8.5.2.2.Saudi Arabia
8.5.2.2.1.Market size and forecast, by protein composition
8.5.2.2.2.Market size and forecast, by form
8.5.2.2.3.Market size and forecast, by age group
8.5.2.2.4.Market size and forecast, by distribution channel
8.5.2.3.South Africa
8.5.2.3.1.Market size and forecast, by protein composition
8.5.2.3.2.Market size and forecast, by form
8.5.2.3.3.Market size and forecast, by age group
8.5.2.3.4.Market size and forecast, by distribution channel
8.5.2.4.Rest of LAMEA
8.5.2.4.1.Market size and forecast, by protein composition
8.5.2.4.2.Market size and forecast, by form
8.5.2.4.3.Market size and forecast, by age group
8.5.2.4.4.Market size and forecast, by distribution channel
8.5.3.LAMEA market size and forecast, by protein composition
8.5.4.LAMEA market size and forecast, by form
8.5.5.LAMEA market size and forecast, by age group
8.5.6.LAMEA market size and forecast, by distribution channel
CHAPTER 9:COMPANY PROFILES
9.1.ABBOTT LABORATORIES
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.B. BRAUN MELSUNGEN AG
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.3.DANONE S.A.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.4.FRESENIUS KABI AG
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.GLOBAL HEALTH PRODUCTS, INC.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.6.HORMEL FOODS CORPORATION
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.7.MEIJI HOLDINGS CO., LTD.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.8.NESTLE S.A
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.RECKITT BENCKISER GROUP PLC.
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.VICTUS, INC.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
LIST OF TABLES
TABLE 01.GLOBAL ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 02.GLOBAL ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 03.ENTERAL NUTRITION MARKET FOR STANDARD PROTEIN DIET, BY REGION, 2018–2027 ($MILLION)
TABLE 04.ENTERAL NUTRITION MARKET FOR STANDARD PROTEIN DIET, BY REGION, 2018–2027 (TONS)
TABLE 05.ENTERAL NUTRITION MARKET FOR HIGH PROTEIN SUPPLEMENT, BY REGION, 2018–2027 ($MILLION)
TABLE 06.ENTERAL NUTRITION MARKET FOR HIGH PROTEIN SUPPLEMENT, BY REGION, 2018–2027 (TONS)
TABLE 07.ENTERAL NUTRITION MARKET FOR PROTEIN FOR DIABETES CARE PATIENT, BY REGION, 2018–2027 ($MILLION)
TABLE 08.ENTERAL NUTRITION MARKET FOR PROTEIN FOR DIABETES CARE PATIENT, BY REGION, 2018–2027 (TONS)
TABLE 09.ENTERAL NUTRITION MARKET FOR OTHERS, BY REGION, 2018–2027 ($MILLION)
TABLE 10.ENTERAL NUTRITION MARKET FOR OTHERS, BY REGION, 2018–2027 (TONS)
TABLE 11.GLOBAL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 12.GLOBAL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 13.ENTERAL NUTRITION MARKET FOR POWDER, BY REGION, 2018–2027 ($MILLION)
TABLE 14.ENTERAL NUTRITION MARKET FOR POWDER, BY REGION, 2018–2027 (TONS)
TABLE 15.ENTERAL NUTRITION MARKET FOR LIQUID, BY REGION, 2018–2027 ($MILLION)
TABLE 16.ENTERAL NUTRITION MARKET FOR LIQUID, BY REGION, 2018–2027 (TONS)
TABLE 17.GLOBAL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 18.GLOBAL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 19.ENTERAL NUTRITION MARKET FOR ADULTS, BY REGION, 2018–2027 ($MILLION)
TABLE 20.ENTERAL NUTRITION MARKET FOR ADULTS, BY REGION, 2018–2027 (TONS)
TABLE 21.ENTERAL NUTRITION MARKET FOR PEDIATRIC, BY REGION, 2018–2027 ($MILLION)
TABLE 22.ENTERAL NUTRITION MARKET FOR PEDIATRIC, BY REGION, 2018–2027 (TONS)
TABLE 23.GLOBAL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 24.GLOBAL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 25.ENTERAL NUTRITION MARKET FOR HOSPITAL SALES, BY REGION, 2018–2027 ($MILLION)
TABLE 26.ENTERAL NUTRITION MARKET FOR HOSPITAL SALES, BY REGION, 2018–2027 (TONS)
TABLE 27.ENTERAL NUTRITION MARKET FOR RETAIL, BY REGION, 2018–2027 ($MILLION)
TABLE 28.ENTERAL NUTRITION MARKET FOR RETAIL, BY REGION, 2018–2027 (TONS)
TABLE 29.ENTERAL NUTRITION MARKET FOR ONLINE, BY REGION, 2018–2027 ($MILLION)
TABLE 30.ENTERAL NUTRITION MARKET FOR ONLINE, BY REGION, 2018–2027 (TONS)
TABLE 31.ENTERAL NUTRITION MARKET, BY REGION, 2018–2027 ($MILLION)
TABLE 32.ENTERAL NUTRITION MARKET, BY REGION, 2018–2027 (TONS)
TABLE 33.NORTH AMERICA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 34.NORTH AMERICA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 35.U.S. ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 36.U.S. ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 37.U.S. ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 38.U.S. ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 39.U.S. ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 40.U.S. ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 41.U.S. ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 42.U.S. ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 43.CANADA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 44.CANADA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 45.CANADA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 46.CANADA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 47.CANADA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 48.CANADA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 49.CANADA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 50.CANADA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 51.MEXICO ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 52.MEXICO ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 53.MEXICO ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 54.MEXICO ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 55.MEXICO ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 56.MEXICO ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 57.MEXICO ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 58.MEXICO ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 59.NORTH AMERICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 60.NORTH AMERICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 61.NORTH AMERICA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 62.NORTH AMERICA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 63.NORTH AMERICA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 64.NORTH AMERICA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 65.NORTH AMERICA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 66.NORTH AMERICA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 67.EUROPE ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 68.EUROPE ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 69.GERMANY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 70.GERMANY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 71.GERMANY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 72.GERMANY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 73.GERMANY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 74.GERMANY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 75.GERMANY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 76.GERMANY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 77.FRANCE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 78.FRANCE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 79.FRANCE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 80.FRANCE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 81.FRANCE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 82.FRANCE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 83.FRANCE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 84.FRANCE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 85.UK ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 86.UK ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 87.UK ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 88.UK ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 89.UK ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 90.UK ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 91.UK ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 92.UK ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 93.ITALY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 94.ITALY ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 95.ITALY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 96.ITALY ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 97.ITALY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 98.ITALY ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 99.ITALY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 100.ITALY ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 101.SPAIN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 102.SPAIN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 103.SPAIN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 104.SPAIN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 105.SPAIN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 106.SPAIN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 107.SPAIN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 108.SPAIN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 109.REST OF EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 110.REST OF EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 111.REST OF EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 112.REST OF EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 113.REST OF EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 114.REST OF EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 115.REST OF EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 116.REST OF EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 117.EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 118.EUROPE ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 119.EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 120.EUROPE ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 121.EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 122.EUROPE ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 123.EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 124.EUROPE ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 125.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 126.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 127.JAPAN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 128.JAPAN ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 129.JAPAN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 130.JAPAN ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 131.JAPAN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 132.JAPAN ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 133.JAPAN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 134.JAPAN ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 135.CHINA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 136.CHINA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 137.CHINA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 138.CHINA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 139.CHINA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 140.CHINA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 141.CHINA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 142.CHINA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 143.AUSTRALIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 144.AUSTRALIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 145.AUSTRALIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 146.AUSTRALIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 147.AUSTRALIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 148.AUSTRALIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 149.AUSTRALIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 150.AUSTRALIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 151.INDIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 152.INDIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 153.INDIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 154.INDIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 155.INDIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 156.INDIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 157.INDIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 158.INDIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 159.SOUTH KOREA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 160.SOUTH KOREA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 161.SOUTH KOREA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 162.SOUTH KOREA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 163.SOUTH KOREA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 164.SOUTH KOREA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 165.SOUTH KOREA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 166.SOUTH KOREA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 167.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 168.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 169.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 170.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 171.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 172.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 173.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 174.REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 175.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 176.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 177.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 178.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 179.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 180.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 181.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 182.ASIA-PACIFIC ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 183.LAMEA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 ($MILLION)
TABLE 184.LAMEA ENTERAL NUTRITION MARKET, BY COUNTRY, 2018–2027 (TONS)
TABLE 185.BRAZIL ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 186.BRAZIL ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 187.BRAZIL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 188.BRAZIL ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 189.BRAZIL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 190.BRAZIL ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 191.BRAZIL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 192.BRAZIL ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 193.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 194.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 195.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 196.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 197.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 198.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 199.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 200.SAUDI ARABIA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 201.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 202.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 203.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 204.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 205.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 206.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 207.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 208.SOUTH AFRICA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 209.REST OF LAMEA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 210.REST OF LAMEA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 211.REST OF LAMEA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 212.REST OF LAMEA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 213.REST OF LAMEA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 214.REST OF LAMEA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 215.REST OF LAMEA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 216.REST OF LAMEA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 217.LAMEA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 ($MILLION)
TABLE 218.LAMEA ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION, 2018–2027 (TONS)
TABLE 219.LAMEA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 ($MILLION)
TABLE 220.LAMEA ENTERAL NUTRITION MARKET, BY FORM, 2018–2027 (TONS)
TABLE 221.LAMEA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 ($MILLION)
TABLE 222.LAMEA ENTERAL NUTRITION MARKET, BY AGE GROUP, 2018–2027 (TONS)
TABLE 223.LAMEA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 ($MILLION)
TABLE 224.LAMEA ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL, 2018–2027 (TONS)
TABLE 225.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 226.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 227.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 228.ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 229.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 230.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 231.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 232.DANONE S.A: COMPANY SNAPSHOT
TABLE 233.DANONE S.A: OPERATING SEGMENTS
TABLE 234.DANONE S.A: PRODUCT PORTFOLIO
TABLE 235.FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 236.FRESENIUS KABI AG: OPERATING SEGMENTS
TABLE 237.FRESENIUS KABI AG: PRODUCT PORTFOLIO
TABLE 238.GLOBAL HEALTH PRODUCTS, INC.: COMPANY SNAPSHOT
TABLE 239.GLOBAL HEALTH PRODUCTS, INC.: PRODUCT PORTFOLIO
TABLE 240.HORMEL FOODS CORPORATION: COMPANY SNAPSHOT
TABLE 241.HORMEL FOODS CORPORATION: OPERATING SEGMENTS
TABLE 242.HORMEL FOODS CORPORATION: PRODUCT PORTFOLIO
TABLE 243.MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT
TABLE 244.MEIJI HOLDINGS CO., LTD.: OPERATING SEGMENTS
TABLE 245.MEIJI HOLDINGS CO., LTD.: PRODUCT PORTFOLIO
TABLE 246.NESTLE S.A: COMPANY SNAPSHOT
TABLE 247.NESTLE S.A: OPERATING SEGMENTS
TABLE 248.NESTLE S.A: PRODUCT PORTFOLIO
TABLE 249.NESTLE S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 250.RECKITT BENCKISER GROUP PLC.: COMPANY SNAPSHOT
TABLE 251.RECKITT BENCKISER GROUP PLC.: OPERATING SEGMENTS
TABLE 252.RECKITT BENCKISER GROUP PLC.: PRODUCT PORTFOLIO
TABLE 253.RECKITT BENCKISER GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 254.VICTUS, INC.: COMPANY SNAPSHOT
TABLE 255.VICTUS, INC.: OPERATING SEGMENTS
TABLE 256.VICTUS, INC.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.ENTERAL NUTRITION MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2020
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.LOW BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2018
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR STANDARD PROTEIN DIET, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR STANDARD PROTEIN DIET, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 15.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR HIGH PROTEIN SUPPLEMENT, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR HIGH PROTEIN SUPPLEMENT, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 17.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR PROTEIN FOR DIABETES CARE PATIENT, BY COUNTRY,2018 & 2027 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR PROTEIN FOR DIABETES CARE PATIENT, BY COUNTRY,2018 & 2027 (TONS)
FIGURE 19.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR OTHERS, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR OTHERS, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 21.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR POWDER, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR POWDER, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 23.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR LIQUID, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR LIQUID, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 25.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR ADULTS (ABOVE 18), BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR ADULTS (ABOVE 18), BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 27.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR PEDIATRIC (BELOW 18), BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR PEDIATRIC (BELOW 18), BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 29.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR HOSPITAL SALES, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR HOSPITAL SALES, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 31.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR RETAIL, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR RETAIL, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 33.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR ONLINE, BY COUNTRY, 2018 & 2027 ($MILLION)
FIGURE 34.COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET FOR ONLINE, BY COUNTRY, 2018 & 2027 (TONS)
FIGURE 35.ABBOTT LABORATORIES: REVENUE, 2018–2020 ($MILLION)
FIGURE 36.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 38.B. BRAUN MELSUNGEN AG: REVENUE, 2018–2020 ($MILLION)
FIGURE 39.B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41.DANONE S.A: REVENUE, 2017–2019 ($MILLION)
FIGURE 42.DANONE S.A: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.DANONE S.A: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 44.FRESENIUS KABI AG: REVENUE, 2018–2020 ($MILLION)
FIGURE 45.FRESENIUS KABI AG: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46.FRESENIUS KABI AG: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 47.HORMEL FOODS CORPORATION: REVENUE, 2018–2020 ($MILLION)
FIGURE 48.HORMEL FOODS CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49.HORMEL FOODS CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 50.MEIJI HOLDINGS CO., LTD.: REVENUE, 2018–2020 ($MILLION)
FIGURE 51.MEIJI HOLDINGS CO., LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52.NESTLE S.A: REVENUE, 2018–2020 ($MILLION)
FIGURE 53.NESTLE S.A: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 54.NESTLE S.A: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 55.RECKITT BENCKISER GROUP PLC.: REVENUE, 2018–2020 ($MILLION)
FIGURE 56.RECKITT BENCKISER GROUP PLC: REVENUE SHARE BY SEGMENT, 2020 (%)
Enteral nutrition is generally recommended for patients suffering from chronic illnesses such as head & neck cancer, dementia, and stroke. In enteral feeding system, nutrition or medications are directly administered in the stomach or intestine.
Enteral feeding is an established medical practice across pediatric and adult population, mainly to increase nutritional intake. Enteral feeding is preferred to intravenous parenteral feeding for those who have normal functioning GI tracts. Elderly and bedridden patients suffering from various chronic ailments such as cancer, neurological disorders, gastro-intestinal, and certain inherited metabolic diseases fuel the demand for enteral feeding devices across regions.
Rise in patients suffering from several chronic conditions, especially adults, is the major factor that drives the growth of the global enteral nutrition market. Other factors such as increase in geriatric population and rise in number of malnutrition cases are expected to have a significant impact on the growth of the market. However, factors such as poor demand and lack of awareness of enteral nutrition in underdeveloped countries hamper the market growth.
The consumption of enteral nutrition is the highest in North America, owing to a large patient population, and is followed by Europe and Asia-Pacific. In addition, enteral nutrition and distributors are focused on expanding their presence in the emerging economies, which in turn is anticipated to drive the market growth.
A. Top companies such as Abbott Laboratories, B. Braun Melsungen AG, and Danone S.A. held a high market position in 2018. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Standard protein diet segment is the most influencing segment owing to higher acceptance of the composition among healthcare professionals, one of the most common types of composition prescribed for patients and different product launches of the standard protein rich products, are known to fulfill the market demand.
A. Rise in prevalence of chronic diseases such as as cancer as well as neurological disorders across the world, surge in the adoption of enteral nutrition over parenteral nutrition, rise in geriatric population, and growth in malnutrition cases drive the growth of the market.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the increase in number of initiatives and enhanced investments from governments for the overall development of Enteral Nutrition, and surge in prevalence of cancer in the region. Moreover, favorable reimbursement policies associated with cancer, diabetes and other chronic diseases treatment, and increase in public awareness towards the usage and benefits of these devices are the key reasons for the significant growth of the market.
A. Enteral nutrition is food supplement that provides nutrients directly in the gastrointestinal tract in patients who cannot swallow food or get enough nourishment by eating or drinking. This process of administrating nutrition involves the usage of enteral feeding devices such as pumps and tubes.
A. Enteral Nutrition products used for management of the nutritional deficits caused due to various chronic conditions, inability to swallow or chew food, whether due to surgical procedures or due to severe mouth ulcers.
A. The total market value of Enteral Nutrition market is $6,762 million in 2018.
A. The forcast period for Enteral Nutrition market is 2020 to 2027
A. The market value of Enteral Nutrition market in 2020 is $7589.76 million.
A. The base year is 2018 in Enteral Nutrition market
Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
